Overall, our study sheds light on how PXN-AS1 facilitates BCR::ABL1-independent resistance to Imatinib in CML cells via the mTOR signaling pathway, mediated by GS. This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.